BioDot Inc., an Irvine-based medical device maker involved in testing for the coronavirus, was acquired March 27 for an undisclosed amount by Boston-based Artemis Capital Partners. The company, ...
The need for accessible, convenient and rapid testing over the course of the pandemic pushed the FDA to temporarily approve over-the-counter COVID-19 tests. That’s one result of the past year that ...
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth IRVINE, ...
OULU, Finland and IRVINE, CA, Oct. 23, 2012 /CNW/ - JOT Automation, a global automation company, has selected BioDot to co-market and sell their automated lateral flow assembly systems in North ...
BUFFALO, N.Y. and IRVINE, Calif., April 24, 2025 /PRNewswire/ -- Empire Genomics, a Biocare Medical company and leader in molecular diagnostics, is proud to announce a strategic partnership with ...
Artemis Capital Partners has acquired Irvine, California-based BioDot Inc, a maker of automated ultralow volume fluid dispensing systems. No financial terms were disclosed. IRVINE, Calif., April 9, ...
CARLSBAD, CA / ACCESSWIRE / December 29, 2015 / University of Rochester (Dr. Phipps), PermeaDerm, Inc. (Dr. Woodroof) and BioDot Inc. (Dr. Lemmo) are collaborating to make a Temporary Skin Substitute ...
IRVINE, Calif.--(BUSINESS WIRE)--To support increasing demand globally for COVID-19 testing, BioDot has compressed production times for most new lateral flow dispensing platforms from months to four ...
BioDot, Inc., a supplier of nanoliter dispensing systems has entered a strategic alliance with Berlin-based Scienion AG, a picoliter liquid handling specialist, to accelerate the development of ...
BioDot and JOT Automation Enter a Co-marketing and Sales Agreement for BioDot to promote and support JOT's lateral flow assembly systems. Andrew Sweet states, "BioDot has been looking to complete its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results